These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8221243)

  • 1. [Types of anticellular structure antisera in scleroderma patients].
    Ni ZM
    Zhonghua Yi Xue Za Zhi; 1993 May; 73(5):270-2, 318. PubMed ID: 8221243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between various autoantibodies in scleroderma patients and their clinical features].
    Su LD
    Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):658-60, 700-1. PubMed ID: 8124613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunofluorescent studies in patients with scleroderma and in their families].
    Szczepański A
    Przegl Dermatol; 1972; 59(6):727-32. PubMed ID: 4566145
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
    Sato S; Hasegawa M; Nagaoka T; Takamatsu Y; Yazawa N; Ihn H; Kikuchi K; Takehara K
    J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients].
    Nebe H; Blume N
    Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251
    [No Abstract]   [Full Text] [Related]  

  • 6. Antinuclear antibodies in localized scleroderma.
    Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
    Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antinuclear antibodies in mesenchymal scleroderma and progressive systemic sclerosis (author's transl)].
    Sugiura M; Hashimoto T; Kurihara S; Nishikawa T; Hatano H
    Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):935-7. PubMed ID: 7012401
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the centrosome antiserum from a scleroderma patient].
    Yin PH; Ni ZM; Shi LJ
    Shi Yan Sheng Wu Xue Bao; 1994 Dec; 27(4):483-95. PubMed ID: 7879575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of anti-Scl-70 antibody and its clinical significance in progressive systemic sclerosis].
    Jiang M
    Zhonghua Yi Xue Za Zhi; 1986 Jun; 66(6):346-8, 384. PubMed ID: 3094898
    [No Abstract]   [Full Text] [Related]  

  • 10. [Scleroderma].
    Scharffetter K; Kind P; Wollny-Protzel D; Schuppe HC; Lakomek HJ; Goerz G
    Z Hautkr; 1990 Mar; 65(3):237-42, 245-6. PubMed ID: 2187309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to fibroblasts in scleroderma.
    Brentnall TJ; Kenneally D; Barnett AJ; de Aizpurua HJ; Lolait SJ; Ashcroft R; Toh BH
    J Clin Lab Immunol; 1982 May; 8(1):9-12. PubMed ID: 7047748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study.
    Arkachaisri T; Fertig N; Pino S; Medsger TA
    J Rheumatol; 2008 Dec; 35(12):2439-44. PubMed ID: 19004036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in childhood scleroderma.
    Bernstein RM; Pereira RS; Holden AJ; Black CM; Howard A; Ansell BM
    Ann Rheum Dis; 1985 Aug; 44(8):503-6. PubMed ID: 3875322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-NuMA antibodies: an uncommon specificity in scleroderma sera.
    Herrera-Esparza R; Avalos-Diaz E; Barbosa-Cisneros O
    Rev Rhum Engl Ed; 1999 Jun; 66(6):315-8. PubMed ID: 10418059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome studies in scleroderma with consideration of anticentromere antibody status and assessment of possible in vitro clastogenic activity.
    Powell FC; Schroeter AL; Winkelmann RK; Dewald GW
    Acta Derm Venereol; 1986; 66(5):414-8. PubMed ID: 2431579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of antinuclear autoantibodies in progressive systemic sclerosis and its clinical significance].
    Jiang M; Wang HZ; Yuan X
    Zhonghua Nei Ke Za Zhi; 1988 Feb; 27(2):112-4, 136. PubMed ID: 3053068
    [No Abstract]   [Full Text] [Related]  

  • 18. [The value of humoral immune phenomena in children and adolescents with circumscribed scleroderma].
    Albrecht-Nebe H; Stojanow K; Ziegler H; Eggert W; Barthelmes H
    Kinderarztl Prax; 1989 Jul; 57(7):315-26. PubMed ID: 2796119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunofluorescence study with an autoantinucleolus antiserum from a scleroderma patient as compared with silver staining].
    Young Y
    Shi Yan Sheng Wu Xue Bao; 1986 Mar; 19(1):39-51. PubMed ID: 2426879
    [No Abstract]   [Full Text] [Related]  

  • 20. Antinuclear antibodies in children with localized scleroderma.
    Rosenberg AM; Uziel Y; Krafchik BR; Hauta SA; Prokopchuk PA; Silverman ED; Laxer RM
    J Rheumatol; 1995 Dec; 22(12):2337-43. PubMed ID: 8835572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.